D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$454M |
| 2 |
Apple
AAPL
|
+$364M |
| 3 |
Procter & Gamble
PG
|
+$314M |
| 4 |
Verizon
VZ
|
+$308M |
| 5 |
Pfizer
PFE
|
+$299M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$735M |
| 2 |
Emerson Electric
EMR
|
+$423M |
| 3 |
Biogen
BIIB
|
+$354M |
| 4 |
PayPal
PYPL
|
+$349M |
| 5 |
Amazon
AMZN
|
+$338M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.77% |
| 2 | Healthcare | 11.58% |
| 3 | Consumer Discretionary | 8.97% |
| 4 | Financials | 7.64% |
| 5 | Communication Services | 5.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1651
CALL
Digital Realty Trust
DLR
$72.4B
| $3.61M | 0.01% |
+26,000
| New | +$3.31M |
|
1652
Smith & Wesson
SWBI
$666M
| $3.61M | 0.01% |
565,234
-323,722
| -36% | -$2.29M |
|
|
AEL
1653
DELISTED
American Equity Investment Life Holding Company
AEL
| $3.6M | 0.01% |
191,571
+20,715
| +12% | +$529K |
|
|
CBAY
1654
DELISTED
Cymabay Therapeutics
CBAY
| $3.58M | 0.01% |
2,419,884
+398,332
| +20% | +$669K |
|
1655
Copart
CPRT
$27.6B
| $3.58M | 0.01% |
209,048
+160,000
| +326% | +$3.56M |
|
|
SCTL
1656
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
| $3.58M | 0.01% |
437,798
+116,500
| +36% | +$1.62M |
|
1657
CALL
Vertex Pharmaceuticals
VRTX
$122B
| $3.57M | 0.01% |
15,000
-5,000
| -25% | -$1.15M |
|
|
FLXN
1658
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $3.57M | 0.01% |
453,494
+132,787
| +41% | +$2M |
|
1659
AZZ Inc
AZZ
$4.47B
| $3.56M | 0.01% |
126,674
+28,000
| +28% | +$1.07M |
|
1660
Matador Resources
MTDR
$5.86B
| $3.56M | 0.01% |
1,436,357
+540,809
| +60% | +$5.94M |
|
1661
CALL
Walt Disney
DIS
$168B
| $3.56M | 0.01% |
36,800
-88,000
| -71% | -$11.1M |
|
|
QVCGA
1662
DELISTED
QVC Group Inc Series A
QVCGA
| $3.53M | 0.01% |
11,921
-66,657
| -85% | -$23.8M |
|
1663
PUT
Western Union
WU
$2.55B
| $3.53M | 0.01% |
194,600
+105,600
| +119% | +$2.59M |
|
|
KL
1664
DELISTED
Kirkland Lake Gold Ltd Ordinary
KL
| $3.51M | 0.01% |
119,125
-339,974
| -74% | -$12.4M |
|
1665
Paycom
PAYC
$7.05B
| $3.5M | 0.01% |
17,334
-80,098
| -82% | -$22M |
|
1666
CALL
Royal Bank of Canada
RY
$291B
| $3.5M | 0.01% |
56,800
-10,000
| -15% | -$742K |
|
1667
Axos Financial
AX
$5.45B
| $3.48M | 0.01% |
191,819
-144,109
| -43% | -$3.62M |
|
1668
CALL
Royal Gold
RGLD
$17.1B
| $3.47M | 0.01% |
39,600
-700
| -2% | -$72.3K |
|
1669
Mitsubishi UFJ Financial
MUFG
$260B
| $3.47M | 0.01% |
948,543
-3,409
| -0.4% | -$16.2K |
|
|
EGRX
1670
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $3.47M | 0.01% |
75,444
+4,052
| +6% | +$203K |
|
1671
Fossil Group
FOSL
$249M
| $3.46M | 0.01% |
1,051,697
-447,814
| -30% | -$2.64M |
|
1672
Ribbon Communications
RBBN
$359M
| $3.46M | 0.01% |
1,140,640
-98,401
| -8% | -$296K |
|
1673
CALL
Lowe's Companies
LOW
$119B
| $3.44M | 0.01% |
40,000
-154,300
| -79% | -$16.9M |
|
|
1674
PUT
Lowe's Companies
LOW
$119B
| $3.44M | 0.01% |
40,000
-20,800
| -34% | -$2.27M |
|
1675
Donnelley Financial Solutions
DFIN
$1.26B
| $3.44M | 0.01% |
652,737
+114,671
| +21% | +$972K |
|
Similar funds
D.E. Shaw & Co's Q1 2020 Portfolio in Review
As of Q1 2020, D.E. Shaw & Co held 4,498 positions worth $64.1B, down 27% from $87.5B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
D.E. Shaw & Co withdrew a net $5.59B in Q1 2020, closing 626 positions and reducing 1,723 holdings. Its most notable exit was PG&E, an estimated $79M position sold in full.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 15% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, D.E. Shaw & Co opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $124M.
- D.E. Shaw & Co's largest Q1 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,005,000 shares worth $124M.
- D.E. Shaw & Co added most to ExxonMobil in Q1 2020, an estimated $454M increase.
- D.E. Shaw & Co's biggest Q1 2020 reduction was Tesla, cutting an estimated $735M.
- D.E. Shaw & Co fully exited PG&E in Q1 2020, selling an estimated $79M.
- D.E. Shaw & Co's ten largest holdings make up 12% of its $64.1B portfolio in Q1 2020.
- D.E. Shaw & Co opened 538 new positions and closed 626 in Q1 2020.
- D.E. Shaw & Co's portfolio value fell 27% quarter-over-quarter to $64.1B.
Based on D.E. Shaw & Co's 13F filing for Q1 2020, filed 15 May 2020.